VTRO (Vitro Biopharma) General and Admin. Expense: $7.60 Mil (TTM As of Oct. 2022)


What is Vitro Biopharma General and Admin. Expense?

Vitro Biopharma VTRO General and Admin. Expense is $7.60 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Vitro Biopharma's General and Admin. Expense for the three months ended in Oct. 2022 was $7.60 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Oct. 2022 was $7.60 Mil.

Vitro Biopharma General and Admin. Expense Related Terms

Vitro Biopharma General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma General and Admin. Expense Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.08 0.33 4.96 7.60

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.08 0.33 4.96 7.60

Vitro Biopharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $7.60 Mil mean?
Vitro Biopharma (VTRO) has a General and Admin. Expense of $7.60 Mil as of Oct. 2022. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's General and Admin. Expense too high?
Vitro Biopharma's current General and Admin. Expense is $7.60 Mil.
How does Vitro Biopharma's General and Admin. Expense compare to ?
Vitro Biopharma's General and Admin. Expense of $7.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current General and Admin. Expense is $7.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current General and Admin. Expense of $7.60 Mil. The current General and Admin. Expense is $7.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current General and Admin. Expense is $7.60 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.